MDWD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MediWound Ltd (MDWD) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company is facing significant financial challenges, including a sharp decline in revenue and net income, and lacks strong positive catalysts. While the technical indicators and options sentiment are neutral to slightly positive, the lack of clear growth prospects and weak financial performance make it prudent to hold off on investing in this stock right now.
The MACD is slightly positive at 0.0085, indicating mild bullish momentum. However, the RSI is neutral at 48.931, and the moving averages suggest a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 17.544, with resistance at 18.094 and support at 16.994.
Gross margin increased significantly by 4574% YoY, indicating some operational efficiency improvements.
Revenue declined by 68% YoY in Q4 2025, primarily due to reduced development services revenue linked to the U.S. government shutdown. Net income and EPS dropped to 0, reflecting a 100% decline YoY. The company is facing significant financial headwinds, and there are no recent insider or hedge fund trading trends to suggest confidence in the stock.
In Q4 2025, MediWound's revenue dropped to $1.87 million (-68.03% YoY). Net income and EPS both fell to 0 (-100% YoY). Despite these declines, gross margin improved significantly to 722.6 (+4574% YoY), but this is insufficient to offset the broader financial struggles.
No recent analyst rating or price target changes were provided. Wall Street sentiment on the stock appears neutral to negative, given the lack of significant positive developments.
